Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement
暂无分享,去创建一个
P. Pibarot | V. Auffret | H. le Breton | A. Cheema | J. Rodés‐Cabau | H. Wijeysundera | E. Dumont | I. Amat-Santos | D. Himbert | J. Paradis | A. Dager | M. Urena | L. M. Benítez | A. Muñoz-García | V. Serra | Leonardo de Freitas Campos Guimarães | B. García Del Blanco | Quentin Fisher
[1] D. Dey,et al. High-pressure post-dilation following transcatheter valve-in-valve implantation in small surgical valves. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[2] M. Taguri,et al. Incidence, Predictors, and Clinical Impact of Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients: The OCEAN-TAVI Registry. , 2018, JACC. Cardiovascular interventions.
[3] P. Pibarot,et al. Long-Term Outcomes Following Surgical Aortic Bioprosthesis Implantation. , 2018, Journal of the American College of Cardiology.
[4] E. Navarese,et al. Comparative performance of transcatheter aortic valve-in-valve implantation versus conventional surgical redo aortic valve replacement in patients with degenerated aortic valve bioprostheses: systematic review and meta-analysis , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] R. Lange,et al. Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve , 2018, Heart.
[6] I. Barbash,et al. Comparison of Outcome of Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis in 3 Age Groups (≤70; 71 to 80, and ≥81 Years). , 2017, The American journal of cardiology.
[7] Jeroen J. Bax,et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.
[8] V. Auffret,et al. Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives , 2017, Circulation.
[9] P. Pibarot,et al. Aortic Bioprosthetic Valve Durability: Incidence, Mechanisms, Predictors, and Management of Surgical and Transcatheter Valve Degeneration. , 2017, Journal of the American College of Cardiology.
[10] D. Dvir,et al. Bioprosthetic Valve Fracture Improves the Hemodynamic Results of Valve-in-Valve Transcatheter Aortic Valve Replacement , 2017, Circulation. Cardiovascular interventions.
[11] L. Fleisher,et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.
[12] J. Leipsic,et al. Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. , 2017, Journal of the American College of Cardiology.
[13] J. Coselli,et al. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. , 2016, Journal of the American College of Cardiology.
[14] J. Zamorano,et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[15] B. Carabello,et al. Operationalizing the 2014 ACC/AHA Guidelines for Valvular Heart Disease: A Guide for Clinicians. , 2016, Journal of the American College of Cardiology.
[16] P. Pibarot,et al. Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry. , 2015, Journal of the American College of Cardiology.
[17] R. Puri,et al. Transcatheter Valve-in-Valve and Valve-in-Ring for Treating Aortic and Mitral Surgical Prosthetic Dysfunction. , 2015, Journal of the American College of Cardiology.
[18] M. Mack,et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.
[19] K. Kuck,et al. Comparison of outcomes of patients with left ventricular ejection fractions ≤30% versus ≥30% having transcatheter aortic valve implantation (from the German Transcatheter Aortic Valve Interventions Registry). , 2015, The American journal of cardiology.
[20] M. Mack,et al. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. , 2014, Journal of the American College of Cardiology.
[21] M. Pasic,et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. , 2014, JAMA.
[22] R. Attia,et al. Effect of valve design on the stent internal diameter of a bioprosthetic valve: a concept of true internal diameter and its implications for the valve-in-valve procedure. , 2014, JACC. Cardiovascular interventions.
[23] A. Cribier,et al. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. , 2013, The American journal of cardiology.
[24] Anson Cheung,et al. 5-year outcome after transcatheter aortic valve implantation. , 2013, Journal of the American College of Cardiology.
[25] J. Webb,et al. Adverse Effects Associated With Transcatheter Aortic Valve Implantation , 2013, Annals of Internal Medicine.
[26] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[27] C. Hengstenberg,et al. Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results From the Global Valve-in-Valve Registry , 2012, Circulation.
[28] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[29] J. Webb,et al. 567 Adverse Effects Associated With Transcatheter Aortic Valve Implantation: A Meta-Analysis of Contemporary Studies , 2012 .
[30] Philippe Pibarot,et al. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. , 2012, European heart journal.
[31] Pascal Vranckx,et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.
[32] P. Serruys,et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.
[33] A. DeAnda,et al. Reoperative valve surgery in the elderly: predictors of risk and long-term survival. , 2010, The Annals of thoracic surgery.
[34] Bijoy K Khandheria,et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Card , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[35] Sean M. O'Brien,et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. , 2009, The Annals of thoracic surgery.
[36] M. Maganti,et al. Redo valvular surgery in elderly patients. , 2009, The Annals of thoracic surgery.
[37] P. Pibarot,et al. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. , 2000, Journal of the American College of Cardiology.
[38] Tania Rodríguez-Gabella,et al. Future of transcatheter aortic valve implantation — evolving clinical indications , 2018, Nature Reviews Cardiology.
[39] Pascal Vranckx,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[40] Sean M. O'Brien,et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. , 2009, The Journal of thoracic and cardiovascular surgery.
[41] J. Chambers,et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.